Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2001
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2407231A1 Cyclic compounds
11/08/2001CA2407129A1 Medicinal formulation comprising pioglitazone
11/07/2001EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
11/07/2001EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
11/07/2001EP1150962A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
11/07/2001EP1150565A1 Thiazole derivatives and combinatorial libraries thereof
11/07/2001EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
11/07/2001EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof
11/07/2001CN1321153A Telomerase inhibitors and method of their use
11/07/2001CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators
11/07/2001CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use
11/07/2001CN1320597A Antifungal and its preparation method and intermediate
11/06/2001US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001US6313305 Cephalosporins
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313164 Dithiolin derivatives, their preparation and their therapeutic effect
11/06/2001US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis
11/06/2001US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001US6313116 Phosphodiesterase inhibitors
11/06/2001US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors
11/06/2001US6313113 Azolidinedione derivatives, analogues, tautomeric forms, stereoisomers, polymorphs, salts and solvates; treating non-insulin-dependent diabetes mellitus
11/06/2001US6313109 Prenyl transferase inhibitors
11/06/2001CA2193178C Matrix metalloprotease inhibitors
11/06/2001CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001WO2001081350A1 Oxazolidinone derivatives with antibiotic activity
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity
11/01/2001WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes
11/01/2001WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators
11/01/2001WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001WO2001080813A2 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
11/01/2001WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001US20010037031 By cyclization of alkynylaminoaromatic, possibly attached to carrier, in polar aprotic solvent with alkali metal compound; drug synthesis
11/01/2001US20010036953 Pyridyl-1,2,5-thiadiazole derivatives
11/01/2001US20010036952 Treatment of alopecia
11/01/2001US20010036947 Pipecolic acid derivative hair growth compositions and uses
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407507A1 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001CA2372673A1 Cyclic amidine compounds
11/01/2001CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP1066281B1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
10/31/2001EP0877026B1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001EP0758326B1 Alkyl sulphinyl and alkyl sulphonyl-1,2,4-thiadiazolyloxy acetamides and their use as herbicides
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001DE10008089A1 Production of tubulysin compounds comprises multi-stage process including condensation of N-methylpipecolinoyl-isoleucine with substituted thiazole-4-carboxylic acid derivative
10/31/2001CN1320124A Benzazoles: benzoxazole, benzthiazole and benzimidazole derivatives
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320120A Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1074013C 3-arylbenzofuranones as stabilisers and its use
10/30/2001US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310069 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
10/30/2001US6310067 Urocanic acid derivatives
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001US6310005 Fungicides, pesticides, insecticides
10/30/2001US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction
10/30/2001CA2216160C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/30/2001CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/30/2001CA2048027C 3-arylindole and 3-arylindazole derivatives
10/25/2001WO2001079203A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds
10/25/2001WO2001079202A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079196A2 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001079187A2 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079170A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof